Pcv29 - Real-World Doac and Vka Use: The Pharmo-Anticoagulation Cohort

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.576
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Guy’s Cancer Cohort – Real World Evidence for Cancer Pathways

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Anticoagulation Treatment With VKA in France, Italy, Germany, Spain and United Kingdom. Results From the React AF Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Practical Implementation of Diabetes Technology: Real‐World Use

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2020English

Report on the Current Status of the Use of Real‐world Data (RWD) and Real‐world Evidence (RWE) in Drug Development and Regulation

British Journal of Clinical Pharmacology
Pharmacology
2019English

Real-World Evidence to Guide the Approval and Use of New Treatments

NAM Perspectives
2016English

Biologically-Inspired Analysis in the Real World: Computing, Informatics, and Ecologies of Use

Security Informatics
2012English

Validation of the Extended Thrombolysis in Cerebral Infarction Score in a Real World Cohort

PLoS ONE
Multidisciplinary
2019English

Pcv108 - Prescribing Choice and the Cost of Anticoagulation in Atrial Fibrillation: A Real World Study Comparing Healthcare Expenditure With Warfarin and Apixaban

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

String Theory and the Real World

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy